Keiichiro Kushiro
NIH Rank #1891
- Top 10% Funded
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16468244Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$4.2M
Full award amounts, FY2025
Award Records
8
Records listing this PI
Award-Linked Rank
#1,891
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Keiichiro Kushiro as a PI. Multi-PI records show the full award amount for context.
- 1R44HD118898-01R44Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception$1.1Maward amount
- 1R44AI192170-01R44IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis$1Maward amount
- 1R43CA310433-01R43Development of MM010, a PEG-specific intervention that blocks allergic response and restores effective repeat dosing of peg-asparaginase in patients with acute lymphoblastic leukemia$409.7Kaward amount
- 1R61HD117428-01R61Development of an ultrapotent anti-sperm antibody construct for non-hormonal contraception$380.7Kaward amount
- 1R43DK143890-01A1R43Development and evaluation of a pegloticase biobetter for sustained suppressionof fructose-induced obesity$359.6Kaward amount
- 1R43AI189008-01R43Engineering a physiologically-tuned reservoir intravaginal ring releasing lactic acid for the treatment and prevention of bacterial vaginosis$310.1Kaward amount
- 75N93025C00021-0-9999-1N43Sustained release of VRC07 from capsule-intravaginal ring for preventing HIV transmission$306.2Kaward amount
- 5R43AI181354-02R43IND-enabling development of MM010, a PEG-specific intervention that blocks allergic response and restores repeated dosing for select PEGylated medicines impacted by anti-PEG antibody$291.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Keiichiro Kushiro as a PI.
FY2025 award administered by Mucommune, Llc (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMucommune, Llc
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1891
- 2025Entered Top 25% NationallyRanked #1891
- 2025Entered Top 10% NationallyRanked #1891
- 2026$5M Cumulative Funding